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OBJECTIVE—To characterize the phenotypic changes of adi-
pose tissue macrophages (ATMs) under different conditions of
insulin sensitivity.
RESEARCH DESIGN AND METHODS—The number and the
expressions of marker genes for M1 and M2 macrophages from
mouse epididymal fat tissue were analyzed using ﬂow cytometry
after the mice had been subjected to a high-fat diet (HFD) and
pioglitazone treatment.
RESULTS—Most of the CD11c-positive M1 macrophages and
the CD206-positive M2 macrophages in the epididymal fat tissue
were clearly separated using ﬂow cytometry. The M1 and M2
macrophages exhibited completely different gene expression
patterns. Not only the numbers of M1 ATMs and the expression
of M1 marker genes, such as tumor necrosis factor- and
monocyte chemoattractant protein-1, but also the M1-to-M2 ratio
were increased by an HFD and decreased by subsequent piogli-
tazone treatment, suggesting the correlation with whole-body
insulin sensitivity. We also found that the increased number of
M2 ATMs after an HFD was associated with the upregulated
expression of interleukin (IL)-10, an anti-inﬂammatory Th2 cyto-
kine, in the adipocyte fraction as well as in adipose tissue. The
systemic overexpression of IL-10 by an adenovirus vector in-
creased the expression of M2 markers in adipose tissue.
CONCLUSIONS—M1 and M2 ATMs constitute different subsets
of macrophages. Insulin resistance is associated with both the
number of M1 macrophages and the M1-to-M2 ratio. The in-
creased expression of IL-10 after an HFD might be involved in the
increased recruitment of M2 macrophages. Diabetes 58:2574–
2582, 2009
O
besity and insulin resistance are closely asso-
ciated with a state of low-grade inﬂammation in
adipose tissue, where resident macrophages
play important roles (1–9). Adipose tissue mac-
rophages (ATMs) consist of at least two different pheno-
types (i.e., classically activated M1 macrophages and
alternatively activated M2 macrophages). A recent report
(10) proposed that M1 or M2 ATMs are distinguished by
the presence or the absence of CD11c, an M1 macrophage
marker. M1 ATMs produce proinﬂammatory cytokines,
such as tumor necrosis factor (TNF)-, interleukin (IL)-6,
and monocyte chemoattractant protein (MCP)-1, thus con-
tributing to the induction of insulin resistance (11–13). On
the other hand, M2 ATMs, which are the major resident
macrophages in lean adipose tissue, are reported to have a
different gene expression proﬁle, characterized by the
relatively high expression of CD206, arginase-1, MglI, and
IL-10, which are involved in the repair or remodeling of
tissues (10–14).
Recent studies have demonstrated the involvement of
M1/M2 ATMs in the regulation of insulin sensitivity. The
deletion of M1 marker genes such as TNF- (15) and C-C
motif chemokine receptor (CCR) 2 (8) or the ablation of
CD11c-positive cells resulted in the normalization of insu-
lin sensitivity (16). On the other hand, the mice with the
macrophage-speciﬁc knockout of peroxisome prolifera-
tor–activated receptor (PPAR)  or PPAR/ displayed
insulin resistance with reduced number and impaired
function of M2 macrophages (17–20). The latter studies
also indicated that IL-4 or IL-13 from adipocytes or hepa-
tocytes promotes the expression of PPAR and PPAR/
in monocytes, resulting in the differentiation of M2 mac-
rophages. Although it is generally accepted that M1 ATMs
induce insulin resistance by secreting a variety of proin-
ﬂammatory cytokines, how M2 ATMs contribute to the
amelioration of insulin resistance is currently unknown.
Recently, Lumeng et al. (10) used CD11c as an M1
marker in a ﬂow cytometry analysis and reported that
high-fat diet (HFD)-induced obesity causes a shift in ATMs
from an M2 polarized state in lean animals to an M1
proinﬂammatory state. However, the precise mechanism
of how the increased ratio of M1 macrophages is induced
in diet-induced obese mice is not fully understood (e.g.,
are M1 macrophages newly recruited from circulating
monocytes, or do M2 macrophages present in lean adipose
tissue differentiate into M1 macrophages?)
To evaluate the changes in the number as well as the
gene expression of M1 and M2 markers more precisely, we
analyzed mouse ATMs by ﬂow cytometry using CD206 as
an M2 marker in addition to using CD11c as an M1
marker. Here, we show that the CD11c-positive/CD206-
negative M1 ATMs and the CD206-positive/CD11c-nega-
tive M2 ATMs constituted distinct populations. The
number of M1 macrophages and the M1-to-M2 ratio are
related to the development of insulin resistance. Inter-
estingly, the overexpression of IL-10 by adenovirus
vector increased the markers of M2 ATMs in adipose
tissue, suggesting that enhanced IL-10 expression by an
HFD and/or pioglitazone treatment may be involved in a
phenotypic switch in ATMs.
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Pioglitazone was kindly provided by Takeda (Tokyo, Japan). A rat monoclonal
antibody against mouse F4/80, a hamster monoclonal antibody against mouse
CD11c, a rat CD206 antibody conjugated with Alexa 647, and a rat MglI antibody
conjugated with Alexa 488 were purchased from AbD-Serotec (Oxford, U.K.). A
rat F4/80 antibody conjugated with ﬂuorescein isothiocyanate and a hamster
CD11c antibody conjugated with phycoerythrin were purchased from
eBiosciences (San Diego, CA) and BD Biosciences (San Jose, CA), respectively.
Maintenance of mice. Six-week-old male C57BL/6J mice were purchased
from CLEA Japan (Meguro-Ku, Japan). The mice were maintained under a
standard light cycle (12 h light/dark) and were allowed free access to water
and food. They were fed a standard diet containing 10% calory from fat (Nosan
Corporation, Yokohama, Japan) or an HFD containing 60% fat (Research
Diets, New Brunswick, NJ) for 17 weeks. During the last 5 weeks of the diet
intervention, half of the mice receiving the HFD were switched to HFD
supplemented with pioglitazone (10 mg  kg
1  day
1). The animal care
policies and procedures for the experiments were approved by the animal
studies committee at the University of Toyama.
Infection of adenovirus vector. A cDNA encoding human IL-10 was
inserted into an adenovirus vector using the Adenovirus Expression Vector Kit
(Ad-hIL-10) (Takara Bio, Shiga, Japan) as described previously (21). Ad-X-
DsRed2 (Ad-R2), an adenovirus vector encoding Discosoma sp. red ﬂuores-
cent protein, was used as a control vector (Clontech, Mountain View, CA).
Ad-hIL-10 or Ad-R2 was injected intraperitoneally.
Immunohistochemistry of macrophages in white adipose tissues. F4/80
staining was performed using an amino acid polymer detection system and
Histoﬁne Mouse Stain Kit (Nichirei, Tokyo, Japan). The sections were
incubated with anti-F4/80 antibody (dilution, 1:100) overnight at 4°C and were
incubated with a secondary antibody of Histoﬁne Simple Stain Max PO (rat)
for 30 min. For CD11c staining, the sections were incubated with hamster
anti-mouse CD11c antibodies (dilution, 1:20) for 3 h, then with goat anti-
hamster IgG antibody (dilution, 1:100) for 1 h, and ﬁnally with Histoﬁne Simple
Stain Max PO (goat) for 30 min. Negative control studies were also performed
without using these ﬁrst antibodies. All sections were counterstained with
hematoxylin. The total number of cells and crown-like structure were counted
in 10 different high-power ﬁelds from each section.
Isolation of adipocytes and stromal-vascular fractions. Epididymal adi-
pose tissues from mice were rinsed in saline, minced into ﬁne pieces, and
digested with collagenase (Sigma-Aldrich, St. Louis, MO) with Krebs-Hense-
leit-HEPES buffer, pH 7.4, supplemented with 20 mg/ml of BSA and 2 mmol/l
glucose at 37°C using a shaker for 45 min. Then, the samples were passed
through a mesh and fractionated by brief centrifugation (1,000 rpm). The
pellets or the ﬂoating cells were collected as the stromal-vascular fraction
(SVF) or as the adipocyte fraction, respectively. Cells in each fraction were
used for RNA extraction or ﬂow cytometry analysis.
Flow cytometry analysis. Cells in the SVF were incubated in Pharm Lyse (BD
Biosciences) for 15 min at 4°C and resuspended in Pharmingen stain buffer (BD
Biosciences). The cells were incubated with 2.4G2 (BD Biosciences) for 10 min
and then with primary antibodies or the matching control isotypes for 30 min at
4°C. Then, the cells were rinsed twice and resuspended in Pharmingen stain
buffer. After incubating with 7-amino-actinomycin D (BD Biosciences), the cells
were analyzed using a FACSAria cell sorter (BD Biosciences). The data analysis
was performed using FlowJo (Tree Star, Ashland, OR). M1 or M2 macrophages
were identiﬁed as F4/80-positive/CD11c-positive/CD206-negative or F4/80-posi-
tive/CD11c-negative/CD206-positive cells, respectively. The numbers of M1 or M2
macrophages were calculated by multiplying the number of trypan blue–negative
cells by the ratio of F4/80-positive/CD11c-positive/CD206-negative cells or that of
F4/80-positive/CD11c-negative/CD206-positive cells.
Quantitative RT-PCR. Total RNA was extracted from epididymal fat tissue
or sorted cells using the RNeasy kit (Qiagen, Hilden, Germany). cDNA was
synthesized with multiscribe reverse transcriptase (Applied Biosystems, Fos-
ter City, CA). Quantitative RT-PCR for each gene was performed using the
TaqMan method (50°C for 2 min, 95°C for 10 min, and 40 cycles of 95°C for 15 s
and 60°C for 1 min) with premade primer sets (Applied Biosystems). The
relative abundance of transcripts was normalized according to the expression
of 18S mRNA and was analyzed using a standard curve method.
Statistical analysis. Results were presented as the means  SE. The data
were analyzed using unpaired t tests. Differences were considered statistically
signiﬁcant at P  0.05.
RESULTS
M1 macrophage markers were increased by high-fat
feeding and decreased by pioglitazone treatment,
while M2 macrophage markers were not. Before test-
ing the effects of high-fat treatment or pioglitazone treat-
ment on ATMs, the effect of these treatments on glucose
metabolism and adipose tissues were examined. High-fat
treatment for 17 weeks increased glucose levels based on
an intraperitoneal insulin tolerance test and a glucose
tolerance test in C57BL/6 mice. Pioglitazone treatment for
the last 5 weeks of 17-week HFD treatment signiﬁcantly
lowered the glucose proﬁle, suggesting an improvement in
insulin sensitivity and glucose metabolism (data not
shown). The average adipocyte size in epididymal fat
tissue was signiﬁcantly larger in high-fat–fed mice than in
mice fed the standard diet. Pioglitazone treatment de-
creased the adipocyte size by 36% (data not shown). We
next examined the changes in the marker genes for
macrophages in epididymal fat tissue with or without
high-fat treatment and pioglitazone treatment. The expres-
sion of F4/80 mRNA was increased by high-fat feeding and
was markedly reduced by pioglitazone treatment (Fig. 1A).
ATMs were recently reported to consist of at least two
subclasses, referred to as M1 and M2 macrophages (12,13).
The expressions of all the M1 markers examined were
regulated very simply by high-fat feeding and pioglitazone
treatment (i.e., the mRNAs of CD11c, TNF-, and MCP-1),
were all upregulated by high-fat feeding, and were down-
regulated by pioglitazone treatment (Fig. 1B–D). On the
other hand, the M2 markers, such as CD206, CD163,
CD209a, and IL-10, were not as simply regulated as those
for the M1 markers (Fig. 1E–H). Some of the M2 markers
were reduced, but others were increased or not altered by
high-fat feeding and pioglitazone treatment. Interestingly,
the expression of IL-10 was increased by high-fat feeding
and was further increased by pioglitazone treatment, al-
though insulin sensitivity was deteriorated by the former
and ameliorated by the latter. These changes in the M2
markers may have arisen as a result of the selective
induction or suppression of such genes.
M1 and M2 macrophage fractions were clearly sepa-
rated by ﬂow cytometry using CD11c and CD206 as
M1 and M2 markers, respectively. Recently, Lumeng et
al. (10) reported that adipose tissue M1 or M2 macro-
phages are deﬁned by the presence or the absence of
CD11c, an M1 marker. In this study, we extended the
report of Lumeng et al. and tried to separate M2 ATMs
using CD206 as an M2 marker. After the ﬁrst sorting of the
F4/80-positive cells from the SVF of epididymal fat tissue
from high-fat–fed mice, the cells were then analyzed by
ﬂow cytometry using CD11c and CD206 as markers of M1
and M2 macrophages, respectively. As shown in Fig. 2A,
clearly separated cell fractions were observed (i.e., most
of the CD11c-positive cells were CD206 negative, whereas
most of the CD11c-negative cells were CD206 positive). As
expected, the fractions showed very different gene expres-
sion proﬁles. CD11c, TNF-, and IL-6 were highly ex-
pressed in the CD11c-positive/CD206-negative fraction but
not in the CD11c-negative/CD206-positive fraction. Con-
versely, CD206, CD163, CD209a, IL-10, and MglII were
highly expressed in the CD11c-negative/CD206-positive
fraction but not in the CD11c-positive/CD206-negative
fraction (Fig. 2B). Accordingly, we identiﬁed the CD11c-
positive/CD206-negative fraction as the M1 fraction and
the CD11c-negative/CD206-positive fraction as the M2
fraction in this study.
Recently, Lumeng et al. (14) identiﬁed MglI-positive
F4/80 macrophages as M2a fraction. Thus, we examined
whether the expression of CD206 was correlated with that
of MglI. Flow cytometry analysis showed that the expres-
sions of these two markers were well correlated as shown
S. FUJISAKA AND ASSOCIATES
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marker as MglI for detecting the M2 fraction.
Numbers of M1 and M2 macrophages were increased
by high-fat feeding and decreased by pioglitazone
treatment. Using this useful cell sorting system, we
further examined whether the changes in M1 and M2
markers observed in whole epididymal fat tissue (Fig. 1)
could be explained by changes in the number of M1 and
M2 macrophages or by changes in the gene expression
proﬁles of each cell. First, the cell numbers in the M1 and
M2 fractions were evaluated in samples obtained from
mice with or without high-fat treatment or pioglitazone
treatment (Fig. 3). The ratio of the M1 fraction in F4/80-
positive cells was increased by high-fat feeding and de-
creased by pioglitazone treatment, while the ratio of the
M2 fraction was conversely decreased by high-fat feeding
and increased by pioglitazone treatment (Fig. 3C). How-
ever, it should be noted that the number of M2 ATMs
normalized according to the weight of the epididymal fat
tissue was increased by high-fat feeding and decreased by
pioglitazone treatment, similar to the changes in M1 ATMs
(Fig. 3D), because the total number of ATMs normalized
according to the weight of the epididymal fat tissue was
remarkably increased by high-fat feeding and decreased by
pioglitazone treatment (Fig. 3B). These results suggest
that the changes in the M1 markers in the whole epididy-
mal fat tissue shown in Fig. 1 can be explained, at least in
part, by the changes in the number of M1 ATMs, while the
various changes in the M2 markers cannot be explained
simply by the changes in the number of M2 ATMs. The
changes in ATMs were also examined by immunostaining.
As previously reported (22), F4/80-positive cells formed
crown-like structures (CLSs) in the epididymal fat tissue
of high-fat–fed mice, which were rarely observed in that of
standard diet–fed mice. Pioglitazone treatment signiﬁ-
cantly decreased the number of CLSs (Fig. 3E). Similar
changes of CD11c-positive CLSs by these treatments were
also observed, indicating that the number of M1 ATMs was
increased by high-fat feeding and decreased by pioglita-
zone treatment (Fig. 3F and G).
Expression of M1 markers in each cell was not al-
tered, but the expression of some M2 markers was
upregulated by pioglitazone treatment. We next eval-
uated the changes in the gene expression proﬁles of each
cell in the M1 and M2 fractions. After sorting the cells into
M1 and M2 fractions, the expressions of several M1 and M2
markers were measured. Because the cell count in the M1
fraction from normal chow-fed mice was very low, the
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FIG. 1. Effect of HFD and pioglitazone on gene expressions of epididymal fat tissue. Total RNA was isolated from the whole epididymal fat tissue,
and real-time RT-PCR for the indicated genes was conducted as described in the RESEARCH DESIGN AND METHODS section. Data were normalized
according to 18S mRNA level and presented as a value relative to that for normal diet–fed mice. The results are shown as means  SE for ﬁve
to eight animals per group. *P < 0.05; **P < 0.01.
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FIG. 2. Gene proﬁles of macrophages positive or negative for CD11c and CD206 in epididymal fat tissue. Cells in the SVF of epididymal fat tissue
from mice fed a HFD for 12 weeks were analyzed using ﬂow cytometry. F4/80-positive cells were further analyzed with anti-CD11c and anti-CD206
antibodies. A: Representative ﬂow cytometry results. Blue dots show isotype control. Total RNA was isolated from F4/80-positive/CD11c-positive/
CD206-negative cells or F4/80-positive/CD11c-negative/CD206-positive cells. B: Real-time RT-PCR for the indicated genes was conducted as
described in the RESEARCH DESIGN AND METHODS section. Data were normalized according to the 18S mRNA level. The results are shown as the
means  SE for four to seven animals per group. *P < 0.05; **P < 0.01. The correlation between CD206 expression and MglI expression was
examined. C: Representative results.
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our usual methods in these mice. Thus, we compared the
expressions of M1 and M2 markers in the M1 and M2
fractions normalized according to the number of macro-
phages only in high-fat–fed mice. The expressions of the
M1 markers in the M1 fraction were not altered by
pioglitazone treatment, whereas some M2 markers, such
as IL-10 and CD209, were selectively increased in the M2
fraction (Fig. 4A–C). Taken together, these results sug-
gest that the expression of M1 markers in whole epidid-
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macrophages, while the expression of M2 markers in
whole tissue strongly reﬂects the gene expressions in
each cell.
High-fat feeding upregulated IL-10 expression in the
adipocyte fraction. We next investigated the expression
of cytokines in the adipocyte fraction, which may regulate
the differentiation or recruitment of ATMs. The expression
of TNF- or IL-6 in the adipocyte fraction was signiﬁcantly
increased or tended to be increased by high-fat feeding,
but the expression of MCP-1 was not (Fig. 5A–C). These
data suggest the involvement of adipocyte-derived TNF-
or IL-6 in the regulation of the proﬁles of ATMs, but the
involvement of MCP-1 was less likely. Kang et al. (19)
recently reported that adipocyte-derived IL-4 and IL-13
upregulate myeloid PPAR to promote the alternative
activation of M2 macrophages. In contrast to Kang et al.’s
report, we could barely detect the gene expressions of IL-4 or
IL-13 in the adipocyte fractions, although they were detected
in the spleen (data not shown). On the other hand, the
expression of IL-10 was signiﬁcantly increased by an HFD
and decreased by pioglitazone treatment (Fig. 5D).
Systemic overexpression of IL-10 by adenovirus vector
increased M2 macrophages in epididymal fat tissue.
IL-10 has also been reported to promote the differentiation
of M2 macrophages (13). To determine the impact of the
enhanced expression of IL-10 in adipose tissue by an HFD
and/or pioglitazone treatment (Fig. 1H and Fig. 4F), we
examined whether IL-10 is involved in M2 macrophage
recruitment to adipose tissue. IL-10 was systemically over-
expressed in both standard diet–fed and high-fat–fed mice
through the intraperitoneal injection of adenovirus vec-
tors. Serum IL-10 levels increased transiently and peaked
at a serum level of 300 pg/ml 4 days after injection (data
not shown). Thus, the effects of IL-10 overexpression on
the ATM proﬁles in epididymal fat tissue were evaluated
on day 4. IL-10 overexpression increased the F4/80 mRNA
in both standard diet–fed and high-fat–fed mice (Fig. 6A).
Unexpectedly, IL-10 overexpression did not suppress the
expression of M1 macrophage markers, such as CD11c,
MCP-1, TNF-, and IL-6 (Fig. 6B–E). Consistent with the
data of M1 markers, IL-10 overexpression did not affect the
number of F4/80-positive CLSs, which are reportedly
formed mainly by M1 macrophages (Fig. 6F). Rather, the
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FIG. 4. Effect of pioglitazone on gene expressions in CD11c-positive and -negative
fractions. Macrophages in the F4/80-positive/CD11c-positive/CD206-negative fraction or
the F4/80-positive/CD11c-negative/CD206-positive fraction of epididymal fat tissue were
sorted using ﬂow cytometry as described in Fig. 2. Total RNA was isolated, and real-time
RT-PCR for the indicated genes was conducted as described in the RESEARCH DESIGN AND
METHODS section. Data were normalized according to the 18S mRNA level. The results are
shown as the means  SE for six animals per group. *P < 0.05.
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CD163, and CD 209a) were markedly upregulated by the
treatment (Fig. 6G–J). These results suggest that the
enhanced expression of IL-10 is involved in the recruit-
ment of M2 macrophages into adipose tissue.
DISCUSSION
Many previous studies (1–3,10) have reported that the
number of ATMs is elevated in both the subcutaneous fat
and epididymal fat tissues of obese human subjects or
rodents. Recently, Lumeng et al. (10) reported that CD11c-
positive ATMs express proinﬂammatory cytokines such as
TNF- and IL-6, while CD11c-negative ATMs express M2
markers such as Ym-1, arginase1, and IL-10. They deﬁned
the former as M1 ATMs and the latter as M2 ATMs. We
extended their report and analyzed the SVF of adipose
tissue using ﬂow cytometry and CD11c and CD206 as M1
and M2 markers, respectively. We found that most of the
CD11c-positive ATMs were CD206 negative and that most
of the CD206-positive ATMs were CD11c negative, indicat-
ing that these two subsets of ATMs constitute distinct
populations (Fig. 2A). As previously reported (10), our
current data also showed that CD11c-positive cells ex-
pressed several proinﬂammatory cytokines, such as TNF-
and IL-6, and that CD206-positive cells expressed very
different gene markers, including CD163, CD209, IL-10,
and MglII (Fig. 2). These results demonstrate that M1 and
M2 macrophages can be more clearly distinguished using
CD206 as an M2 marker in addition to using CD11c as an
M1 marker. Recently, Lumeng et al. (14) used MglIa sa
surface marker for M2 macrophages and identiﬁed an M2
macrophage population that expresses IL-10 at high levels.
Our ﬂow cytometry analysis showed that the expression of
CD206 and MglI were strongly correlated (Fig. 2C). We
believe that CD206 is as good a marker as MglI for
detecting M2 populations. As for double-negative cells for
CD206 and CD11c, these cells expressed lower levels of
M1 markers such as TNF- and IL-6 than CD11c single-
positive F4/80-positive cells. In addition, they expressed
lower levels of M2 markers such as MglII, IL-10, and CD163
than CD206 single-positive F4/80-positive cells (data not
shown). It seems that they are a less mature or less
polarized type of macrophages.
Similar to previous reports (10), our present study
showed that diet-induced obesity increased the number of
CD11c-positive/CD206-negative M1 macrophages by 65-
fold, when normalized according to the weight of epidid-
ymal fat (Fig. 3D). On the other hand, the number of
CD11c-negative/CD206-positive M2 macrophages per
weight basis was also increased by sixfold (Fig. 3D),
although the ratio of M1-to-M2 macrophages was in-
creased (Fig. 3C). The primary trigger for the recruitment
of M1 macrophages is thought to be the secretion of TNF-
from enlarged adipocytes (3). This cytokine is presumed
to stimulate preadipocytes and endothelial cells to pro-
duce MCP-1, thus recruiting monocytes into the adipose
tissue and stimulating M1 ATM differentiation (6,10). In
contrast, the molecular signals that trigger the recruitment
of M2 macrophages in obese adipose tissues are not fully
understood. The activation of PPAR signaling in macro-
phages has also been reported to be necessary for the
alternative activation of ATMs (17,23). It was recently
demonstrated that in response to adipocyte-derived Th2
cytokines, including IL-4 and IL-13, the expression of
PPAR/ was induced, thus leading to the differentiation
or recruitment of the alternative M2 phenotype in Kupffer
cells and ATMs in mice (19,20). We found that the gene
expression of IL-10 was elevated in both adipose tissue
and adipocyte fraction in obese mice (Figs. 1H and 5D).
Furthermore, the systemic overexpression of IL-10 in-
creased M2 macrophages in epididymal fat tissue (Fig. 6).
Thus, we speculated that the activation of IL-10 signaling
as well as IL-4/IL-13 in monocytes may contribute to the
increase in M2 ATMs.
Since IL-10 gene expression is increased in both the
adipocyte fraction and the macrophage fraction, we spec-
ulated that IL-10 might be involved in M2 macrophage
recruitment under HFD conditions. Adipocyte enlarge-
ment is known to be observed earlier than the accumula-
tion of macrophages in adipose tissue (1,2,6). Thus, the
increased expression of IL-10 in larger adipocytes might
trigger the recruitment of M2 macrophages at an earlier
stage. In contrast, pioglitazone reduced the number of M2
macrophages, while upregulating the expression of IL-10.
We presume that factors other than IL-10, which should be
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reduced number of M2 macrophages.
We also compared the expression of the IL-10 gene in
the adipocyte fraction and the M2 macrophage fraction.
We found that the expression of IL-10 in M2 macrophages
was 100-fold higher than that in adipocytes (data not
shown), suggesting that M2 macrophage–derived IL-10
constitutes a major portion of the IL-10 in adipose tissue.
Thus, the pioglitazone-induced increase in the whole adi-
pose tissue can be explained by the increased expression
of IL-10 in the M2 macrophages. Meanwhile, the reduced
expression of IL-10 in the adipocytes had a minimal affect
on the whole adipose tissue after pioglitazone treatment.
Then, what is the role of M2 macrophages in terms of
insulin resistance? IL-10 is reported to improve insulin-
stimulated glucose uptake in TNF-–treated 3T3-L1 adipo-
cytes (10). In fact, our preliminary results indicated that
IL-10 overexpression using adenovirus vector improves
insulin sensitivity in standard diet–fed and high-fat–fed
mice. Thus, it may be possible that adipose tissue/M2
ATM–derived IL-10 may contribute not only to anti-inﬂam-
matory effects in adipose tissue but also to improving
insulin signaling in adipocytes.
Whether the increase in the M1-to-M2 ratio in obese
mice is due to the transdifferentiation of M2 macrophages
into M1 macrophages or the de novo recruitment of
monocytes into the adipose tissue has been a topic of
investigation. Because our data showed that the numbers
of both M1 and M2 macrophages increased, we presumed
that the phenotypic shift of ATMs toward an M1-dominant
0
1
2
3
4
5
6
F
4
/
8
0
 
p
o
s
i
t
i
v
e
 
C
L
S
(
/
1
0
0
0
 
c
e
l
l
s
)
D
0
2
4
6
CD206 
0
1
2
3
4
Ym1 G H
NC HFD
0
1
2
3
4
5
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
(
A
U
)
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
(
A
U
)
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
(
A
U
)
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
(
A
U
)
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
(
A
U
)
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
(
A
U
)
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
(
A
U
)
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
(
A
U
)
R
e
l
a
t
i
v
e
 
e
x
p
r
e
s
s
i
o
n
(
A
U
)
F4/80 
0
1
2
3
4
MCP-1 A B C
IL-10 R2 IL-10 R2
NC HFD
IL-10 R2 IL-10 R2
0 
2 
4 
6 
8 
CD11c
n.s.
0
1
2
3
4
TNF-α
0
1
2
3
4
IL-6
I
J
0
1
2
3
4
CD163
0
2
4
6
CD209a
Ad-vector
NC HFD
IL-10 R2 IL-10 R2 Ad-vector
NC HFD
IL-10 R2 IL-10 R2 Ad-vector
NC HFD
IL-10 R2 IL-10 R2 Ad-vector
NC HFD
IL-10 R2 IL-10 R2 Ad-vector
NC HFD
IL-10 R2 IL-10 R2 Ad-vector
NC HFD
IL-10 R2 IL-10 R2 Ad-vector
NC HFD
IL-10 R2 IL-10 R2 Ad-vector
Ad-vector
NC HFD
IL-10 R2 IL-10 R2 Ad-vector
F
n.s. ** *
**
**
** *
*
* *           *
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
n.s.
E
α α α α
FIG. 6. Effect of IL-10 overexpression on macrophage genes in epididymal fat tissue. Mice
were fed with a normal chow (NC) or a HFD and were subsequently injected with either
Ad-hIL-10 (IL-10) or a control vector (R2), then killed 4 days after injection. Puriﬁcation of
the mRNA and real-time RT-PCR for the indicated genes were performed as described in the
RESEARCH DESIGN AND METHODS section. F: Epididymal fat tissues were stained with anti-F4/80
antibody. Then the number of CLSs was counted, as described in the RESEARCH DESIGN AND
METHODS section. Results are shown as the mean  SE of at least four mice per group. *P <
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macrophages to M1 macrophages but rather by the de
novo recruitment of circulating monocytes to adipose
tissue followed by their differentiation into M1 and M2
macrophages. Consistent with this scenario, a recent
report by Lumeng et al. (14) also demonstrated that
pulse-labeled ATMs were recruited from spatially distinct
regions to the adipose tissue of diet-induced obese mice.
Pioglitazone reduced the number of both M1 and M2
ATMs. We previously hypothesized that the size of adipo-
cytes is inversely related to insulin sensitivity based on the
observation that a thiazolidinedione increased the number
of smaller adipocytes and decreased the number of larger
adipocytes (24,25). Since larger adipocytes produce more
reactive oxygen species (ROS), ROS might be one of the
triggers that recruit macrophages into adipose tissue (26).
Once a thiazolidinedione is administered, the decreased
ROS production by smaller adipocytes may result in the
reduction in the total number of ATMs. The marked
reduction of M1 ATMs may explain, at least in part, the
hypothesis that smaller adipocytes are associated with
insulin sensitivity. As for M2 ATMs, the increased expres-
sion of IL-10 after pioglitazone treatment may explain the
observation that the reduction of the M2 number was less
than that of the M1 ATM number. Pioglitazone may
directly bind to the peroxisome proliferator response
element sites in the IL-10 gene promoter and stimulate the
IL-10 gene expression within macrophages (23,27). The
increased expression of IL-10 by pioglitazone may contrib-
ute to the amelioration of insulin resistance (28–30).
In this study, we identiﬁed two clearly separate macro-
phage fractions in ﬂow cytometry analysis using CD206 as
a marker for M2 macrophages in addition to CD11c, a
well-established M1 marker. These two fractions exhibited
completely different gene expression patterns. We found
that the number of M1 ATMs and M1-to-M2 ratio were
closely associated with insulin resistance in an HFD plus
pioglitazone group as well as an HFD group. Furthermore,
we also suggested that IL-10 upregulated under HFD
conditions might be involved in M2 macrophage recruit-
ment, thus contributing to reducing inﬂammation and
improving insulin signal.
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